Contract award · W81XWH20C0112
DHA 2020.1 SBIR DIRECT TO PHASE II MEDICAL R&D CONTRACT FOR PROPOSAL #H2D-0023, TITLED: "DEPLOYABLE WOUND CARE PRODUCTS TO DECREASE PREVENTABLE DEATH OUTCOMES BY MITIGATING INFECTION ON BATTLEFIELD AND THROUGH LONG TERM CARE"
Awarded to KERICURE INC. · CAGE 692P8
Latest reported total obligated
Not reported
Net observed obligations
$2.2M
Observed contract actions
4
Observed period
FY2020–FY2023
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorKERICURE INC.
CAGE692P8
CustomerDepartment of the Army
Performance locationWESLEY CHAPEL, FLORIDA, UNITED STATES
Procurement details
First observed actionSep 24, 2020
Latest observed actionDec 15, 2022
PSCAN91
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003420R1DSB
Annual observed obligations
FY2020
$1.1M
FY2022
$1.1M
Continue exploring
Ask Mimir about W81XWH20C0112
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.